AI-Guided Hit Compound Derivative Generation for Target Proteins
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Traditional drug development processes are lengthy and costly, with low success rates due to limitations in screening methods, particularly in processing large datasets and predicting protein-ligand binding affinities, leading to inefficiencies in identifying effective drug candidates.
Innovation Solution
A method for generating derivatives of a hit compound by selecting a substitutable portion in its chemical structure, setting a target space within the target protein, and replacing the substitutable portion with a substituent that enhances binding affinity, utilizing a computational system and AI drug platform.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional screening methods are used to identify drug candidates, then the process is simple and straightforward, but the success rate is low and the development time is lengthy (average 15 years)
Solution Approach 1:
The patent performs preliminary computational analysis of protein-ligand binding affinities before actual drug development. By using AI models to predict binding affinities and generate optimized derivatives in advance, the system identifies promising candidates virtually, reducing the need for extensive physical screening and accelerating the overall development timeline while improving success rates.
Solution Approach 2:
The patent replaces traditional mechanical/physical screening methods with computational AI-based systems. Instead of relying on labor-intensive wet lab screening and manual analysis, the system uses machine learning models to predict binding affinities, generate derivatives, and prioritize candidates, dramatically reducing both time and resource requirements while enhancing reliability.
2Reliability
If large datasets are processed to improve screening reliability, then the accuracy of drug candidate identification increases, but the computational complexity and processing time increase significantly
Solution Approach 1:
The patent segments the complex computational task into distinct modules: protein structure analysis, ligand binding prediction, derivative generation, and affinity optimization. Each module processes specific aspects of the data independently, allowing parallel computation and reducing overall system complexity while maintaining high reliability through comprehensive data analysis.
Solution Approach 2:
The patent introduces AI models as intermediary components between raw data and final drug candidate selection. These models process and interpret large datasets, transforming complex computational problems into manageable predictions of binding affinities and derivative optimizations, thereby reducing the apparent complexity of the overall system.
3Productivity
If computational methods are used to predict protein-ligand binding affinities, then the screening efficiency improves, but the accuracy of predictions may be insufficient for reliable drug candidate selection
Solution Approach 1:
The patent employs dynamic AI models that adapt and learn from training data to improve prediction accuracy. The system uses machine learning algorithms that continuously refine their predictions based on known protein-ligand interactions, allowing the computational method to maintain high screening efficiency while progressively improving prediction precision through iterative optimization.
Solution Approach 2:
The patent optimizes multiple parameters including protein structure features, ligand properties, and binding interaction characteristics to enhance prediction accuracy. By adjusting and refining these parameters based on training data and validation results, the system achieves reliable binding affinity predictions that maintain high screening efficiency while improving measurement precision.
Data Source
AI summary
A method for generating a hit compound derivative from a hit compound for a target protein, the method comprising: (A) selecting a substitutable portion and a scaffold excluding the substitutable portion in a chemical structure of the hit compound; (B) setting a target space within the target protein, around a region where the selected substitutable portion of the hit compound binds; and (C) selecting a substituent that can replace the substitutable portion of the hit compound within the set target space of the target protein, and generating the hit compound derivative.